✦ LIBER ✦

Exploring novel cognitive outcomes for clinical trials in MCI and Alzheimer's disease compared with the ADAS-Cog

✍ Scribed by Mark Marsico; Arwen Markwick; Julie Chandler; Xingshu Zhu; Celeste de Jager

Book ID: 118467988
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 51 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.05.1000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association between brain amyloidosis, s

Association between brain amyloidosis, synaptic dysfunction and cognitive performance measured with ADAS-cog and MMSE scores in early MCI, late MCI and Alzheimer's disease

✍ Marina Dauar; Jared Rowley; Liyong Wu; Monica Shin; Sara Mohades; Vladimir Fonov 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 225 KB

The ADAS-cog and clinically meaningful c

The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease

✍ Kenneth Rockwood; Sherri Fay; Mary Gorman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

## Abstract ## Background A minimum 4‐point change at 6 months on the Alzheimer's disease assessment scale‐cognitive subscale (ADAS‐cog) is deemed clinically important, but this cut‐point has been little studied in relation to clinical meaningfulness. In an investigator‐initiated, clinical trial o

The relationship between CRA ADAS-Cog tr

The relationship between CRA ADAS-Cog training and performance on monitoring ADAS-Cogs at clinical sites in an Alzheimer's disease clinical trial

✍ Meyer, Stephen; Perez, Magdalena; Little, Crystal; Soto, Jay; Moriarty, David 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Establishing threshold scores and profil

Establishing threshold scores and profiles of cognitive impairment for the Alzheimer's Disease Assessment Scale–Cognitive Subscale (ADAS-Cog) for patients with higher dementia (MMSE < 12), Alzheimer's disease and probable MCI

✍ Yavorsky, Christian; DiClemente, Guillermo; Opler, Mark; Khan, Anzalee; Jovic, S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P4-373: Predictors of placebo group decl

P4-373: Predictors of placebo group decline in the Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog) in 24-week clinical trials of Alzheimer's disease

✍ Irizarry, Michael C.; Webb, David J.; Bains, Chanchal; Barrett, Steven J.; Lai, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 109 KB

P4-387: Adding delayed recall to the Alz

P4-387: Adding delayed recall to the Alzheimer's disease assessment scale–cognitive subscale (ADAS-cog): Sensitivity in a clinical trial for Alzheimer's disease and mild cognitive impairment

✍ Raman, Rema; Emond, Jennifer; Thomas, Ronald G.; Petersen, Ronald C.; Schneider, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 102 KB